DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 Healthcare Data Breach: What it Means for Companies and the Consumer? Visit Post
2 How Healthcare Apps are Adding New Perspectives to the Healthcare Industry? Visit Post
3 Reliable Experts in Pharmacology Market: Pharma Consultants Visit Post
4 Business Consultants: An Intense Drive to Work Excellence Visit Post
5 Analyzing the Prospects of Drones in Healthcare Delivery System Visit Post
6 Top 7 Pharma Industry Leaders in 2020 By the Numbers Visit Post
7 FDA approval to Keytruda and Lenvima; FibroGen's Roxadustat; Pfizer’s TICOVAC; Ipsen’s Palovarotene; Jazz Pharma’s Xywav; Seagen-RemeGen’s Cancer Medicine Visit Post
8 Reimagining Clinical Trials: Why are Virtual Clinical Trials Becoming the New Normal? Visit Post
9 Technological Innovation: The Medicine of Healthcare Visit Post
10 MedTech Wrap Up Visit Post
11 Wearable Devices: Weighing the Potential Benefits and Pitfalls of the Innovative Wearable Products Visit Post
12 Aelis Farma pockets $30M; Alcyone unveils $23M for AAV gene therapies; Progentec and GSK collaborate; Kozin bags $60M Visit Post
13 What factors are guiding the Growth of Endoscopy Fluid Management Systems in the MedTech Market? Visit Post
14 Latest Medtech Commercial, Regulatory and Clinical Updates For - Abbott, BD, CooperVision, Procyrion, TricValve, and others Visit Post
15 Which Companies are Vying to get a Major Chunk in the Elastomeric Pump Market? Visit Post
16 MedTech Industry: Commercial, Regulatory and Clinical Updates Visit Post
17 The Rising Burden of Substance Use Disorder And The Treatment Scenario Visit Post
18 MedTech Industry Roars Back as FDA Approvals Soar Visit Post
19 E-Pharmacies: A Disruptive Innovation and the Future of Pharma Sector Visit Post
20 Merck, Gilead teams up for HIV treatment; Bright Future for Sanofi/Regeneron’s Libtayo; Roche acquires GenMark; FDA okays Melinta's Kimyrsa Visit Post
21 Diagnosing At-Home: Are At-Home Diagnostic Tools The New Trends? Visit Post
22 Bluebird suspends gene therapy trials; Cortexyme tripped up by FDA hold; Guardant Health launches surveillance blood test; Enhertu scores approval Visit Post
23 Healthcare in 2021: Top Disruptions Bound To Impact The Way Healthcare Is Delivered Visit Post
24 Merck, Eisai in renal cancer market; G1 Therapeutics on Cosela’s approval; Takeda's Maribavir; Astellas/Seagen Padcev Visit Post
25 Pfizer/ OPKO Health’s Somatrogon; FDA EU for SCONE device; Antengene ATG-010 for rrMM and rrDLBCL; SanBio STEMTRA Phase 2 Interim Results Visit Post
26 Alcohol Use Disorder (AUD): When Drinking Becomes A Headache Visit Post
27 Treating Patients with Software: Digital Therapeutics Visit Post
28 Will Wearable Devices be Streamlined in Healthcare? Visit Post
29 Creating Future of MedTech Industry with Artificial Intelligence Visit Post
30 Bioterrorism: A Threat To The Healthcare And Global Peace Visit Post
31 Trump vs. Biden: What is in Store for Healthcare Domain? Visit Post
32 How Will Artificial Intelligence Change The Future Of Healthcare? Visit Post
33 Adding Value to the Health with a Value-Based Healthcare Model Visit Post
34 The State of Alternative Medicine In The Healthcare Visit Post
35 Healthcare Delivery System: What lies in the future? Visit Post
36 EicOsis receives USD 15M to fuel its non-opioid pain therapy; Alexion Pharmaceuticals buys Achillion Pharmaceuticals; Ipsen adds another drug to its rare disease pipeline Visit Post
37 ImaginAb joins hands with AstraZeneca, Pfizer, Takeda Visit Post
38 Sanifit nets USD 80.9 M; FDA approves Dupixent for CRS; AbbVie buys Allergan Visit Post
39 Notizia Visit Post
40 Complex regional pain syndrome (CRPS)-A debilitating disease Visit Post
41 The Business Cocktail Visit Post
42 Approach for Cystic Fibrosis; An alternative for Statins; Oral medications not safe; Carbon monoxide poisoning treatment gets approval Visit Post
43 BioNTech lines up $800M; Deerfield remunerates; Britain's Smith & Nephew to acquire Osiris Visit Post
44 Welcome the Slumber Visit Post
45 NO SMOKING DAY Visit Post
46 Wearing Technology to stay fit Visit Post
47 ColdZyme inactivates viruses; Med for rare genetic disease; Common oral bacteria accelerate Colon cancer; CEPI and CureVac to develop an mRNA vaccine; Celastrol’s effectiveness Visit Post
48 Biodesix collaborates with MRM; Avoiding flu with an antibody; Soliris clears trial Visit Post
49 Juvenescence raises $46M; Brainsway files for IPO; Life Biosciences raises Visit Post
50 Apollomics raises; Pear Therapeutics raises $64M; Lilly to acquire Loxo Visit Post
51 Vedanta raises; Relay Therapeutics reels in; Gene therapy for SMA Visit Post
52 Prometic bags $50M; Vedanta receives $12M; Humira biosimilar deal Visit Post
53 Newsletter Visit Post
54 Notizia Visit Post
55 Cholera vaccine delivered; Rice-inspired breakthroughs; International partnerships Visit Post
56 Notizia Visit Post
57 Epic Sciences garners; Tvardi gets financing; Galera raises; Fund for cancer research Visit Post
58 Business Cocktail Visit Post
59 Immune Checkpoint Activators (ICA): Dynamic Therapeutic Targets Visit Post
60 Business Cocktail Visit Post
61 In vivo monitoring of T cell–dendritic cell interactions by intercellular enzymatic labelling Visit Post
62 Adapsyn signed; Evolus filed; BioNTech signed a deal; Nordisk’s deal Visit Post
63 Business Cocktail Visit Post
64 December 7 Business Cocktail Visit Post
65 Toll-Like Receptor Modulators: Emerging therapy for many indications Visit Post
66 Ketamine to work in mice Visit Post
67 EMA to relocate to Amsterdam; Roche’s prospects; Amgen’s Humira Biosimilar delayed; Purdue’s opioid lawsuit Visit Post
68 Chemists may help solve the air-pollution health crisis Visit Post
69 CAR-T Phase I trials; ContraVir Announces; Merck acquired; Excision BioTherapeutics bags $10M Visit Post
70 Novartis on AMD drug; Hospira recall of vials; Takeda wraps up; FDA bans imports Visit Post
71 Bio-manufacturing with Spider Silk for pre-term babies Visit Post
72 Chemotherapy-Induced Nausea and Vomiting Side effects Visit Post
73 Acromegaly and Gigantism: It’s all about excessive Growth Hormone… Visit Post
74 Valeant's asset-sale; Sanofi coughs up $19.8M; Sanofi's Genzyme; India's Alkem; GSK’s inhalers Visit Post
75 Medical tourism in India Visit Post
76 BioAsia 2017 Visit Post
77 Payers block EpiPen; Allergan charged; AbbVie's Humira; Baxter paying $18M Visit Post
78 Biosimilars: A benchmark in Pharmaceutical Business Visit Post
79 Aurobindo takes top generic spot; Valeant unloads Dendreon; Ipsen strikes $1B deal; Takeda shells out $5.2B Visit Post
80 Sanofi, Regeneron one step closer; Pharma's deal; J&J and Actelion deal Visit Post
81 Novartis Buys; FDA approves; Mayne Pharma Launches; Oxford Genetics Receives Grant Visit Post
82 Fresenius Kabi introduced Bivalirudin; Envigo Launches; Mylan's MAA accepted; Pricing hit pharma Visit Post
83 Merck launches Biosimilars, ABITEC announces extension, First human clinical trial, FDA awards 2grants, Corden Pharma Expands, Juniper Pharma Services Offers Visit Post
84 JAK Inhibitors: New Lifeline for Hair Loss Treatment Visit Post
85 Bayer AG & Evotec AG’s deal; Plasticell and CellSpring AG’s deal; Allergan Acquires Akarna; Cambrex Acquires Pharmacore Visit Post
86 Sygnis AG and ECACC Collaboration; BioNTech and Genentech Partnership; Partnership between Zydus Cadila and Takeda; Global Agreement between Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Visit Post
87 NATCO Pharma surges; AstraZeneca falls; US patent office rules Visit Post
88 Lupin acquired; FDA grants approval; NATCO gets approval; Wockhardt Ltd. gets import alert; Patent fight Visit Post